The bitcoin of Biotech is about to go down

Short

CRISPR Therapeutics AG (NASDAQ:CRSP)

Updated

NASDAQ:CRSP CRISPR Therapeutics AG

I view CRSP as one of the most interesting biotechnology stocks out there. DYOR. If it works, it will be huge. I am happy to see there will be opportunities to accumulate some stock, after I short it into my ideal entry levels.

Comment:

approaching target 1

Comment:

CRSP is in long term accumulation zone. It's a buy anywhere between 32 - 24 as a long term hold.

Comment:

This trade did extremely well from an execution standpoint. The technicals are now indicating to me that price may reach close to $200 per share in the next year or two. This stock has all the signs of being a superior long term hold.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.